Age associated changes of AGE-receptor expression: RAGE upregulation is associated with human heart dysfunction

Experimental Gerontology

Volumn 39, Issue 3, 2004, Pages 407-413

  Simm, A ^a   Casselmann C ^a   Schubert, A ^b   Hofmann, S ^a   Reimann, A ^a   Silber, R E ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Advanced glycation endproducts; Ageing; Cardiac index; Heart; Human; Receptor

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; ADVANCED GLYCATION END PRODUCT RECEPTOR 3; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; AGED; AGING; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; HEART ATRIUM; HEART DISEASE; HUMAN; HUMAN TISSUE; PATHOPHYSIOLOGY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENESCENCE; WESTERN BLOTTING;

EID: 1342286733     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exger.2003.12.006     Document Type: Article

References (64)

1. Asif M., Egan J., Vasan S., Jyothirmayi G.N., Masurekar M.R., Lopez S., Williams C., Torres R.L., Wagle D., Ulrich P., et al. An advanced glycation endproduct crosslink breaker can reverse age-related increases in myocardial stiffness. Proc. Natl Acad. Sci. USA. 97:2000;2809-2813.
2. Aubin J.E., Liu F., Malaval L., Gupta A.K. Osteoblast and chondroblast differentiation. Bone. 17:1995;77S-83S.
3. Baynes J.W. The Maillard hypothesis on aging: time to focus on DNA. Ann. NY Acad. Sci. 959:2002;360-367.
4. Bierhaus A., Illmer T., Kasper M., Luther T., Quehenberger P., Tritschler H., Wahl P., Ziegler R., Muller M., Nawroth P.P. Advanced glycation end product (AGE)-mediated induction of tissue factor in cultured endothelial cells is dependent on RAGE. Circulation. 96:1997;2262-2271.
5. Bierhaus A., Schiekofer S., Schwaninger M., Andrassy M., Humpert P.M., Chen J., Hong M., Luther T., Henle T., Kloting I., et al. Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes. 50:2001;2792-2808.
6. Boulanger E., Wautier M.P., Wautier J.L., Boval B., Panis Y., Wernert N., Danze P.M., Dequiedt P. AGEs bind to mesothelial cells via RAGE and stimulate VCAM-1 expression. Kidney Int. 61:2002;148-156.
7. Breitling-Utzmann C.M., Unger A., Friedl D.A., Lederer M.O. Identification and quantification of phosphatidylethanolamine-derived glucosylamines and aminoketoses from human erythrocytes - influence of glycation products on lipid peroxidation. Arch. Biochem. Biophys. 391:2001;245-254.
8. Brownlee M. The pathological implications of protein glycation. Clin. Invest. Med. 18:1995;275-281.
9. Bucciarelli L.G., Wendt T., Rong L., Lalla E., Hofmann M.A., Goova M.T., Taguchi A., Yan S.F., Yan S.D., Stern D.M., Schmidt A.M. RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease. Cell Mol. Life Sci. 59:2002;1117-1128.
10. Bulteau A.L., Verbeke P., Petropoulos I., Chaffotte A.F., Friguet B. Proteasome inhibition in glyoxal-treated fibroblasts and resistance of glycated glucose-6-phosphate dehydrogenase to 20 S proteasome degradation in vitro. J. Biol. Chem. 276:2001;45662-45668.
11. Caßelmann, C., Reimann, A., Friedrich, I., Schubert, A., Silber, R.E., Simm, A. Age-dependent Expression of Advanced Glycation Endproduct (AGE)-Receptor Genes in the Human Heart. Gerontology, in press.
12. Corman B., Duriez M., Poitevin P., Heudes D., Bruneval P., Tedgui A., Levy B.I. Aminoguanidine prevents age-related arterial stiffening and cardiac hypertrophy. Proc. Natl Acad. Sci. USA. 95:1998;1301-1306.
13. Dagher S.F., Wang J.L., Patterson R.J. Identification of galectin-3 as a factor in pre-mRNA splicing. Proc. Natl Acad. Sci. USA. 92:1995;1213-1217.
14. Daoud S., Schinzel R., Neumann A., Loske C., Fraccarollo D., Diez C., Simm A. Advanced glycation endproducts: activators of cardiac remodeling in primary fibroblasts from adult rat hearts. Mol. Med. 7:2001;543-551.
15. DeGroot J., Verzijl N., Budde M., Bijlsma J.W., Lafeber F.P., TeKoppele J.M. Accumulation of advanced glycation end products decreases collagen turnover by bovine chondrocytes. Exp. Cell Res. 266:2001;303-310.
16. Fehrenbach H., Weiskirchen R., Kasper M., Gressner A.M. Up-regulated expression of the receptor for advanced glycation end products in cultured rat hepatic stellate cells during transdifferentiation to myofibroblasts. Hepatology. 34:2001;943-952.
17. Friguet B., Bulteau A.L., Chondrogianni N., Conconi M., Petropoulos I. Protein degradation by the proteasome and its implications in aging. Ann. NY Acad. Sci. 908:2000;143-154.
18. Gupta S.K., Masinick S., Garrett M., Hazlett L.D. Pseudomonas aeruginosa lipopolysaccharide binds galectin-3 and other human corneal epithelial proteins. Infect. Immun. 65:1997;2747-2753.
19. Halle J.P., Muller S., Simm A., Adam G. Copy number, epigenetic state and expression of the rRNA genes in young and senescent rat embryo fibroblasts. Eur. J. Cell Biol. 74:1997;281-288.
20. Hattori Y., Suzuki M., Hattori S., Kasai K. Vascular smooth muscle cell activation by glycated albumin (Amadori adducts). Hypertension. 39:2002;22-28.
21. He C.J., Zheng F., Stitt A., Striker L., Hattori M., Vlassara H. Differential expression of renal AGE-receptor genes in NOD mice: possible role in nonobese diabetic renal disease. Kidney Int. 58:2000;1931-1940.
22. Heine R.J., Dekker J.M. Beyond postprandial hyperglycaemia: metabolic factors associated with cardiovascular disease. Diabetologia. 45:2002;461-475.
23. Hirai M., Shimizu N. Purification of two distinct proteins of approximate Mr 80,000 from human epithelial cells and identification as proper substrates for protein kinase C. Biochem. J. 270:1990;583-589.
24. Hong S.B., Lee K.W., Handa J.T., Joo C.K. Effect of advanced glycation end products on lens epithelial cells in vitro. Biochem. Biophys. Res. Commun. 275:2000;53-59.
25. Huang J.S., Guh J.Y., Chen H.C., Hung W.C., Lai Y.H., Chuang L.Y. Role of receptor for advanced glycation end-product (RAGE) and the JAK/ STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells. J. Cell Biochem. 81:2001;102-113.
26. Husedzinovic I., Barisin S., Tonkovic D., Sostaric S. Measuring cardiac output during dobutamine infusion after off-pump coronary artery bypass: comparison of transesophageal echo-Doppler and thermodilution. Croat. Med. J. 43:2002;680-684.
27. Huttunen H.J., Fages C., Kuja-Panula J., Ridley A.J., Rauvala H. Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis. Cancer Res. 62:2002;4805-4811.
28. Kass D.A., Shapiro E.P., Kawaguchi M., Capriotti A.R., Scuteri A., deGroof R.C., Lakatta E.G. Improved arterial compliance by a novel advanced glycation endproduct crosslink breaker. Circulation. 104:2001;1464-1470.
29. Kirigiti P., Bai Y., Yang Y.F., Li X., Li B., Brewer G., Machida C.A. Agonist-mediated down-regulation of rat beta1-adrenergic receptor transcripts: role of potential post-transcriptional degradation factors. Mol. Pharmacol. 60:2001;1308-1324.
30. Kuwabara I., Liu F.T. Galectin-3 promotes adhesion of human neutrophils to laminin. J. Immunol. 156:1996;3939-3944.
31. Lander H.M., Tauras J.M., Ogiste J.S., Hori O., Moss R.A., Schmidt A.M. Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. J. Biol. Chem. 272:1997;17810-17814.
32. Li Y.M., Mitsuhashi T., Wojciechowicz D., Shimizu N., Li J., Stitt A., He C., Banerjee D., Vlassara H. Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins. Proc. Natl Acad. Sci. USA. 93:1996;11047-11052.
33. Liu F.T., Hsu D.K., Zuberi R.I., Kuwabara I., Chi E.Y., Henderson W.R. Jr. Expression and function of galectin-3, a beta-galactoside-binding lectin, in human monocytes and macrophages. Am. J. Pathol. 147:1995;1016-1028.
34. Lyons T.J., Silvestri G., Dunn J.A., Dyer D.G., Baynes J.W. Role of glycation in modification of lens crystallins in diabetic and nondiabetic senile cataracts. Diabetes. 40:1991;1010-1015.
35. Mathur S., Devaraj S., Jialal I. Accelerated atherosclerosis, dyslipidemia, and oxidative stress in end-stage renal disease. Curr. Opin. Nephrol. Hypertens. 11:2002;141-147.
36. Mazurek N., Conklin J., Byrd J.C., Raz A., Bresalier R.S. Phosphorylation of the beta-galactoside-binding protein galectin-3 modulates binding to its ligands. J. Biol. Chem. 275:2000;36311-36315.
37. Miyata T., Hori O., Zhang J., Yan S.D., Ferran L., Iida Y., Schmidt A.M. The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-beta2microglobulin with human mononuclear phagocytes via an oxidant sensitive pathway. Implications for the pathogenesis of dialysis-related amyloidosis. J. Clin. Invest. 98:1996;1088-1094.
38. Ochieng J., Warfield P., Green-Jarvis B., Fentie I. Galectin-3 regulates the adhesive interaction between breast carcinoma cells and elastin. J. Cell Biochem. 75:1999;505-514.
39. Oldfield M.D., Bach L.A., Forbes J.M., Nikolic-Paterson D., McRobert A., Thallas V., Atkins R.C., Osicka T., Jerums G., Cooper M.E. Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). J. Clin. Invest. 108:2001;1853-1863.
40. Openo K.P., Kadrofske M.M., Patterson R.J., Wang J.L. Galectin-3 expression and subcellular localization in senescent human fibroblasts. Exp. Cell Res. 255:2000;278-290.
41. Park L., Raman K.G., Lee K.J., Lu Y., Ferran L.J. Jr., Chow W.S., Stern D., Schmidt A.M. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat. Med. 4:1998;1025-1031.
42. Perillo N.L., Marcus M.E., Baum L.G. Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death. J. Mol. Med. 76:1998;402-412.
43. Pugliese G., Pricci F., Leto G., Amadio L., Iacobini C., Romeo G., Lenti L., Sale P., Gradini R., Liu F.T., Di Mario U. The diabetic milieu modulates the advanced glycation end product-receptor complex in the mesangium by inducing or upregulating galectin-3 expression. Diabetes. 49:2000;1249-1257.
44. Pugliese G., Pricci F., Iacobini C., Leto G., Amadio L., Barsotti P., Frigeri L., Hsu D.K., Vlassara H., Liu F.T., Di Mario U. Accelerated diabetic glomerulopathy in galectin-3/AGE receptor 3 knockout mice. FASEB J. 15:2001;2471-2479.
45. Rattan S.I. Synthesis, modifications, and turnover of proteins during aging. Exp. Gerontol. 31:1996;33-47.
46. Schleicher E.D., Wagner E., Nerlich A.G. Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging. J. Clin. Invest. 99:1997;457-468.
47. Sell D.R., Kleinman N.R., Monnier V.M. Longitudinal determination of skin collagen glycation and glycoxidation rates predicts early death in C57BL/6NNIA mice. FASEB J. 14:2000;145-156.
48. Stern D.M., Yan S.D., Yan S.F., Schmidt A.M. Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes. Ageing Res. Rev. 1:2002;1-15.
49. Stitt A.W., Burke G.A., Chen F., McMullen C.B., Vlassara H. Advanced glycation end-product receptor interactions on microvascular cells occur within caveolin-rich membrane domains. FASEB J. 14:2000;2390-2392.
50. Sun M., Yokoyama M., Ishiwata T., Asano G. Deposition of advanced glycation end products (AGE) and expression of the receptor for AGE in cardiovascular tissue of the diabetic rat. Int. J. Exp. Pathol. 79:1998;207-222.
51. Thornalley P.J. Cell activation by glycated proteins. AGE receptors, receptor recognition factors and functional classification of AGEs. Cell Mol. Biol. (Noisy-le-grand). 44:1998;1013-1023.
52. Throckmorton D.C., Brogden A.P., Min B., Rasmussen H., Kashgarian M. PDGF and TGF-beta mediate collagen production by mesangial cells exposed to advanced glycosylation end products. Kidney Int. 48:1995;111-117.
53. Tsay Y.G., Lin N.Y., Voss P.G., Patterson R.J., Wang J.L. Export of galectin-3 from nuclei of digitonin-permeabilized mouse 3T3 fibroblasts. Exp. Cell Res. 252:1999;250-261.
54. Verzijl N., DeGroot J., Oldehinkel E., Bank R.A., Thorpe S.R., Baynes J.W., Bayliss M.T., Bijlsma J.W., Lafeber F.P., Tekoppele J.M. Age-related accumulation of Maillard reaction products in human articular cartilage collagen. Biochem. J. 350:(Pt 2):2000;381-387.
55. Vlassara H., Palace M.R. Diabetes and advanced glycation endproducts. J. Intern. Med. 251:2002;87-101.
56. Vlassara H., Li Y.M., Imani F., Wojciechowicz D., Yang Z., Liu F.T., Cerami A. Identification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE): a new member of the AGE-receptor complex. Mol. Med. 1:1995;634-646.
57. Wang L., Friess H., Zhu Z., Frigeri L., Zimmermann A., Korc M., Berberat P.O., Buchler M.W. Galectin-1 and galectin-3 in chronic pancreatitis. Lab. Invest. 80:2000;1233-1241.
58. Westwood M.E., Argirov O.K., Abordo E.A., Thornalley P.J. Methylglyoxal-modified arginine residues - a signal for receptor-mediated endocytosis and degradation of proteins by monocytic THP-1 cells. Biochim. Biophys. Acta. 1356:1997;84-94.
59. Wolffenbuttel B.H., Boulanger C.M., Crijns F.R., Huijberts M.S., Poitevin P., Swennen G.N., Vasan S., Egan J.J., Ulrich P., Cerami A., Levy B.I. Breakers of advanced glycation end products restore large artery properties in experimental diabetes. Proc. Natl Acad. Sci. USA. 95:1998;4630-4634.
60. Xiang G., Schinzel R., Simm A., Munch G., Sebekova K., Kasper M., Niwa T., Schmitz C., Heidland A. Advanced glycation end products (AGEs)-induced expression of TGF-beta 1 is suppressed by a protease in the tubule cell line LLC-PK1. Nephrol. Dial. Transplant. 16:2001;1562-1569.
61. Yamanouchi J., Takatori A., Nishida E., Kawamura S., Yoshikawa Y. Expression of lipoprotein receptors in the aortic walls of diabetic APA hamsters. Exp. Anim. 51:2002;33-41.
62. Yoshii T., Fukumori T., Honjo Y., Inohara H., Kim H.R., Raz A. Galectin-3 phosphorylation is required for its anti-apoptotic function and cell cycle arrest. J. Biol. Chem. 277:2002;6852-6857.
63. Zhou X., Prado G.N., Chai M., Yang X., Taylor L., Polgar P. Posttranscriptional destabilization of the bradykinin B1 receptor messenger RNA: cloning and functional characterization of the 3′-untranslated region. Mol. Cell Biol. Res. Commun. 1:1999;29-35.
64. Zhu W., Sano H., Nagai R., Fukuhara K., Miyazaki A., Horiuchi S. The role of galectin-3 in endocytosis of advanced glycation end products and modified low density lipoproteins. Biochem. Biophys. Res. Commun. 280:2001;1183-1188.